ArticleLeukemia2015
Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells.
W Fiskus et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
73 papers cite itlatest 60 shown
this papercites it